Skip to main content

Table 2 Preoperative clinicopathological data of all patients enrolled

From: The impact of COVID-19 on gastric cancer surgery: a single-center retrospective study

Clinicopathologic data PCG(N = 68)
M (IQR) orN (%)
CG (N = 41)
M (IQR) orN (%)
P
Admission waiting (day) 4.5 (2–7.75) 8.0 (2–20) 0.006*
Operation waiting (day) 3 (2–5) 7 (5–9) 0.000*
Comorbidity    0.144
 Yes 46 22  
 No 22 19  
Tumor marker    0.298
 CEA 2.12 1.85 0.771
 AFP 2.85 3.01 0.883
 CA199 9.70 9.63 0.863
 CA724 2.03 2.13  
Clinical TNM stage    0.112
 I 17 4  
 II 18 14  
 III 30 23  
 IV 3 0  
Hemoglobin 138.50 (119.25–148.75) 143.00 (119.50–151.00) 0.726
Chest CT scan    0.000*
 Yes 24 30  
 No 44 11  
  1. PCG Pre-COVID-19 group, CG COVID-19 group, CT Computed tomography; c, N Number
  2. * P < 0.05, statistically different